Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MARKEL GROUP INC. Capital/Financing Update 2019

May 20, 2019

30227_rns_2019-05-20_f9762c91-e9a3-44b5-a037-f671ed705942.zip

Capital/Financing Update

Open in viewer

Opens in your device viewer

8-K 1 a8-kdocumentdebtofferingma.htm 8-K html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd" Document created using Wdesk 1 Copyright 2019 Workiva Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

_______________________________________________

FORM 8-K

_______________________________________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 15, 2019

_______________________________________________

Markel Corporation

(Exact name of registrant as specified in its charter)

_______________________________________________

Virginia 001-15811 54-1959284
(State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)
4521 Highwoods Parkway Glen Allen, Virginia 23060-6148
(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (804) 747-0136

Not Applicable

(Former name or former address, if changed since last report)

_______________________________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, no par value MKL New York Stock Exchange, Inc.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company []

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. []

Item 8.01 Other Events.

On May 15, 2019, Markel Corporation (the Company) executed an Underwriting Agreement and related pricing agreement (the Underwriting Agreement) with the underwriters named therein. Under the Underwriting Agreement, the Company is issuing $600,000,000 aggregate principal amount of its 5.000% Senior Notes due 2049 (the Securities) under the Indenture dated as of June 5, 2001 (the Indenture), between the Company and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as trustee, relating to debt securities, as amended by a Thirteenth Supplemental Indenture to the Indenture with respect to the Securities (the Thirteenth Supplemental Indenture). The Underwriting Agreement and the Thirteenth Supplemental Indenture are filed as exhibits hereto and are incorporated herein by reference. The form of the Securities is included as Exhibit A to the Thirteenth Supplemental Indenture.

Certain exhibits are filed herewith by the Company in connection with the Company’s offering of the Securities pursuant to its Prospectus Supplement, dated May 15, 2019, to the Prospectus, dated February 23, 2018, filed with the Securities and Exchange Commission (the Commission) as part of the Registration Statement on Form S-3ASR (Registration No. 333-223194), which became effective February 23, 2018.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

1.1 Underwriting Agreement and related pricing agreement, dated as of May 15, 2019, between Markel Corporation and the underwriters named therein (filed herewith)
4.1 Indenture, dated as of June 5, 2001, between Markel Corporation and The Bank of New York Mellon (as successor to The Chase Manhattan Bank), as Trustee (incorporated by reference from Exhibit 4.1 in the Registrant's report on Form 8-K filed with the Commission June 5, 2001)
4.2 Thirteenth Supplemental Indenture, dated as of May 20, 2019, between Markel Corporation and The Bank of New York Mellon, including form of 5.000% Senior Notes due 2049 as Exhibit A (filed herewith)
5.1 Opinion of McGuireWoods LLP (filed herewith)
23.1 Consent of McGuireWoods LLP (contained in Exhibit 5.1 filed herewith)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MARKEL CORPORATION — By: /s/ Richard R. Grinnan
Name: Richard R. Grinnan
Title: General Counsel and Secretary